Page last updated: 2024-08-17

spironolactone and 3-nitrotyrosine

spironolactone has been researched along with 3-nitrotyrosine in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (55.56)	29.6817
2010's	4 (44.44)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, SS; Lu, L; Quinn, MT; Sun, Y; Weber, KT; Zhang, J	1
Ahokas, RA; Bhattacharya, SK; Gerling, IC; Herring, PA; Lu, L; Postlethwaite, AE; Sun, Y; Warrington, KJ; Weber, KT; Wodi, LA	1
Colucci, WS; Kotlyar, E; Kuster, GM; Liao, R; Rude, MK; Sam, F; Siwik, DA	1
Ahokas, RA; Baburyan, NY; Bhattacharya, SK; Deshmukh, PA; Gandhi, MS; Gerling, IC; Johnson, PL; Kamalov, G; Sun, Y; Weber, KT	1
Kinouchi, T; Kitazato, KT; Nagahiro, S; Satomi, J; Shimada, K; Tada, Y; Tamura, T; Yagi, K	1
DeMarco, VG; Habibi, J; Ma, L; Pulakat, L; Rainey, WE; Sowers, JR; Whaley-Connell, AT	1
Christou, DD; English, M; Hwang, MH; Kim, HK; Luttrell, M; Meade, TH; Segal, MS; Yoo, JK	1
Conte, D; Minas, JN; Nishiyama, A; Ortiz, RM; Thorwald, MA; Vázquez-Medina, JP	1
Alzoubi, KH; Bonyan, R; Mayyas, F	1

Trials

1 trial(s) available for spironolactone and 3-nitrotyrosine

Article	Year
Mineralocorticoid receptors modulate vascular endothelial function in human obesity. Clinical science (London, England : 1979), 2013, Volume: 125, Issue:11 Topics: Abdominal Fat; Aged; Body Composition; Body Mass Index; Brachial Artery; Cross-Over Studies; Double-Blind Method; Endothelial Cells; Eplerenone; F2-Isoprostanes; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Obesity; Oxidative Stress; Receptors, Mineralocorticoid; Spironolactone; Tyrosine; Ultrasonography	2013

Article

Year

Mineralocorticoid receptors modulate vascular endothelial function in human obesity.

Clinical science (London, England : 1979), 2013, Volume: 125, Issue:11

Topics: Abdominal Fat; Aged; Body Composition; Body Mass Index; Brachial Artery; Cross-Over Studies; Double-Blind Method; Endothelial Cells; Eplerenone; F2-Isoprostanes; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Obesity; Oxidative Stress; Receptors, Mineralocorticoid; Spironolactone; Tyrosine; Ultrasonography

2013

Other Studies

8 other study(ies) available for spironolactone and 3-nitrotyrosine

Article	Year
Aldosterone-induced inflammation in the rat heart : role of oxidative stress. The American journal of pathology, 2002, Volume: 161, Issue:5 Topics: Aldosterone; Animals; Antioxidants; Cardiomyopathies; Cell Division; Cell Movement; Fibrosis; Heart; Immunologic Factors; Inflammation; Lymphocytes; Macrophages; Male; Mineralocorticoid Receptor Antagonists; Monocytes; Myocardium; NADPH Oxidases; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spironolactone; Tyrosine	2002
Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. Circulation research, 2003, Nov-14, Volume: 93, Issue:10 Topics: Aldosterone; Animals; Calcium; Cell Separation; Coronary Vessels; Disease Models, Animal; Disease Progression; Gene Expression Profiling; Gene Expression Regulation; Genes, MHC Class II; Hydrogen Peroxide; Hyperaldosteronism; Leukocytes, Mononuclear; Lymphocyte Activation; Magnesium; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Nephrectomy; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spironolactone; Tyrosine	2003
Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation, 2005, Feb-01, Volume: 111, Issue:4 Topics: Animals; Aorta; Apoptosis; Blood Pressure; Cell Size; Chronic Disease; Constriction, Pathologic; Drug Evaluation, Preclinical; Eplerenone; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Intercellular Adhesion Molecule-1; Ligation; Male; Matrix Metalloproteinases; Mice; Mineralocorticoid Receptor Antagonists; Myocarditis; Myocardium; Myocytes, Cardiac; Oxidative Stress; Pressure; Random Allocation; Receptors, Mineralocorticoid; Spironolactone; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tyrosine	2005
Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism. Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:5 Topics: Aldehydes; Aldosterone; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Disease Models, Animal; Glutathione Peroxidase; Homeostasis; Hydrogen Peroxide; Hyperaldosteronism; Male; Metallothionein; Mineralocorticoid Receptor Antagonists; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spironolactone; Superoxide Dismutase; Tyrosine; Zinc	2009
Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cerebral Arteries; Chemokine CCL2; Eplerenone; Female; Gene Expression; Hypertension, Renal; Immunohistochemistry; Intracranial Aneurysm; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Ovariectomy; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Tyrosine	2009
Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression. American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:4 Topics: Animals; Blood Pressure; Cardiomegaly; Endomyocardial Fibrosis; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Reactive Oxygen Species; Renin-Angiotensin System; Spironolactone; Tyrosine; Vasodilator Agents; Ventricular Dysfunction, Left	2011
Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats. Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:11 Topics: Adrenal Glands; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Eplerenone; Heart Diseases; Hypertension; Lipid Peroxidation; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Oxidative Stress; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction; Spironolactone; Time Factors; Tyrosine	2015
The role of spironolactone on myocardial oxidative stress in rat model of streptozotocin-induced diabetes. Cardiovascular therapeutics, 2017, Volume: 35, Issue:2 Topics: Aldosterone; Animals; Blood Pressure; Catalase; Cytochrome P-450 CYP11B2; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Lipid Peroxidation; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Nitrites; Oxidation-Reduction; Oxidative Stress; Rats, Sprague-Dawley; Spironolactone; Streptozocin; Superoxide Dismutase; Time Factors; Tyrosine; Vitamin E	2017